
Spiroglumide
CAS No. 137795-35-8
Spiroglumide( —— )
Catalog No. M36133 CAS No. 137795-35-8
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 240 | Get Quote |
![]() ![]() |
5MG | 371 | Get Quote |
![]() ![]() |
10MG | 561 | Get Quote |
![]() ![]() |
25MG | 868 | Get Quote |
![]() ![]() |
50MG | 1178 | Get Quote |
![]() ![]() |
100MG | 1557 | Get Quote |
![]() ![]() |
500MG | 3114 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSpiroglumide
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
DescriptionSpiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
Recptorcholecystokinin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number137795-35-8
-
Formula Weight441.35
-
Molecular FormulaC21H26Cl2N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](NC(=O)C1=CC(Cl)=CC(Cl)=C1)CCC(O)=O)(=O)N2CCC3(CC2)CCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
SR146131
SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
-
JNJ-26070109
A novel, potent, selective orally active CCK-2 receptor antagonist with pKi of 8.49 for hCCK2.
-
Itriglumide
Itriglumide (CR-2945) is a cholecystokinin (CCK)-2 receptor antagonist with antisecretory and antiulcerogenic properties.